Speaker illustration

Doctor David Garcia Vega

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

Combined sodium-glucose-transporters inhibitors (SGLT2i) and glucagon-like-peptide receptor agonist (GLP1ra) compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

Event: ESC Congress 2024

Topic: Antidiabetic Pharmacotherapy

Session: Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?

Thumbnail

Impact of a clinician-to-clinician electronic consultation program in heart failure patients with previous hospitalization. Implications for heart failure multidisciplinary management.

Event: ESC Congress 2024

Topic: Electronic Medical Records

Session: Innovations in heart failure management: insights from clinical practice and healthcare data

Thumbnail

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry.

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: From obesity to prediction of outcomes in acute heart failure

Thumbnail

Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Cancer and other risk factors for heart disease

Thumbnail

Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry

Event: Heart Failure 2024

Topic: Antidiabetic Pharmacotherapy

Session: Tailoring heart failure therapies on patient profiles

Thumbnail

Impact of a clinician-to-clinician electronic consultation program in heart failure patients with previous hospital admissions. Implications for heart failure multidisciplinary management.

Event: Heart Failure 2024

Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support

Session: e-Cardiology/digital health

Thumbnail

Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: ePosters in acute heart failure 10

Thumbnail

Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Diabetes and the heart (2)

Thumbnail

A universal electronic consultation programme at the cardiology department after general practitioner referrals improves healthcare outcomes in patients with health failure

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcomes in acute heart failure

Thumbnail

An electronic consultation programme impacts on heart failure patients prognosis: implications for heart failure care

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: Epidemiology, prognosis, and outcomes in acute heart failure

Thumbnail